During the past decade, Palo Alto Medical Foundation-Fremont conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 18 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 18 clinical trials were completed. i.e. 78.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palo Alto Medical Foundation-Fremont" #1 sponsor was "National Cancer Institute (NCI)" with 37 trials, followed by "SWOG Cancer Research Network" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palo Alto Medical Foundation-Fremont" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Brain Science Foundation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Palo Alto Medical Foundation-Fremont" are "Invasive Breast Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials) and "Stage IVB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Palo Alto Medical Foundation-Fremont" in a lesser frequency.

Most popular intervention types in "Palo Alto Medical Foundation-Fremont" are "Drug" (54 trials), "Other" (43 trials), "Biological" (33 trials), "Procedure" (26 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (19 trials), "Computed Tomography" (18 trials), "Biospecimen Collection" (16 trials) and "Nivolumab" (11 trials). Other intervention names were less common.

The vast majority of trials in "Palo Alto Medical Foundation-Fremont" are 59 trials for "All" genders, 11 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Palo Alto Medical Foundation-Fremont". undefined are not yet recruiting, 22 are recruiting, 37 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Palo Alto Medical Foundation-Fremont, 3 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Palo Alto Medical Foundation-Fremont, 1 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".